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Abstract
Introduction Poor leptomeningeal collateral flow is related to
worse clinical outcome in acute ischemic stroke, but the fac-
tors that determine leptomeningeal collateral patency are
largely unknown. We explored the determinants of
leptomeningeal collateral flow and assessed their effect on
the relation between leptomeningeal collateral flow and clin-
ical outcome.
Methods We included 484 patients from the Dutch acute
stroke study (DUST) with a middle cerebral artery (MCA)
occlusion. The determinants of poor leptomeningeal collateral
flow (≤50 % collateral filling) were identified with logistic
regression. We calculated the relative risk (RR) of poor
leptomeningeal collateral flow in relation to poor clinical
outcome (90-day modified Rankin Scale 3–6) using Poisson
regression and assessed whether the determinants of
leptomeningeal collateral flow affected this relation.
Results Leptomeningeal collateral flow was poor in 142 pa-
tients (29 %). In multivariable analyses, higher admission glu-
cose level (odds ratio (OR) 1.1 per mmol/L increase (95 % CI
1.0–1.2)), a proximal MCA occlusion (OR 1.9 (95 % CI 1.3–
3.0)), and an incomplete posterior circle of Willis (OR 1.7
(95 % CI 1.1–2.6)) were independently related to poor
leptomeningeal collateral flow. Poor leptomeningeal collateral
flow was related to poor clinical outcome (unadjusted RR 1.7
(95 % CI 1.4–2.0)), and this relation was not affected by the
determinants of leptomeningeal collateral flow.
Conclusion Our study shows that admission glucose level, a
proximal MCA occlusion, and an incomplete ipsilateral pos-
terior circle of Willis are determinants of leptomeningeal col-
lateral flow that represent a combination of congenital, ac-
quired, and acute factors. After adjustment for these determi-
nants, leptomeningeal collateral flow remains related to clini-
cal outcome.
Keywords Leptomeningeal collateral flow . Ischemic stroke .
Stroke etiology . Clinical outcome . CTangiography
Introduction
Leptomeningeal collaterals are a network of small blood ves-
sels connecting distal regions of the intracerebral arterial sys-
tem [1, 2]. They can provide an alternative route for blood
flow to the brain in case of a disruption of the primary blood
flow andmay therefore protect brain tissue against irreversible
damage in case of acute ischemia. Presence of good
leptomeningeal collateral flow has been associated with better
functional outcomes and smaller infarct volumes after acute
ischemic stroke [3–20]. However, factors that determine var-
iation in leptomeningeal collateral flow between patients are
largely unknown. Previous studies suggested genetic factors
[21] and the vascular risk profile, such as prior hypertension
[12, 22, 23], age [22–24], statin use [24], metabolic syndrome
[22], and circle of Willis completeness [2], to be related to the
patency of leptomeningeal collaterals, but some findings of
these studies are contradictory. The presence of an internal
carotid artery stenosis or occlusion might also be related to
the amount of leptomeningeal collateral flow. In addition,
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factors that occur at the time of stroke, including higher sys-
tolic blood pressure at admission [12], higher blood glucose
levels [22], and the location of the occlusion [4], may deter-
mine leptomeningeal collateral patency.
In the last decade, CT angiography (CTA) has been suc-
cessfully incorporated into acute stroke imaging protocols in
many stroke centers worldwide and recently has been proven
useful to select patients for intra-arterial treatment [25–29].
CTA also offers the possibility to assess the leptomeningeal
collateral flow, the circle of Willis, and the extracranial cervi-
cal vessels [30]. Leptomeningeal collaterals themselves can-
not be visualized directly on CTA, but their patency can be
determined by assessing the amount of vascular enhancement
in the affected brain area distal of the occluded artery [4, 8].
This is referred to as leptomeningeal collateral flow.
In the present study, we explored possible determinants of
leptomeningeal collateral flow in a large prospective cohort of
stroke patients with an occlusion of the middle cerebral artery
(MCA). We investigated the relation between leptomeningeal
collateral flow and clinical outcome and assessed whether this




All patients participated in the Dutch acute stroke study
(DUST), a prospective observational cohort study in six uni-
versity and eight non-university hospitals in The Netherlands
[19]. A detailed description of the DUST study protocol has
been published previously [31]. The DUST study population
consists of patients with symptoms of acute ischemic stroke of
less than 9-h duration, who were enrolled between May 2009
and August 2013. Patients with another diagnosis on admis-
sion non-contrast CT (NCCT) such as intracranial hemorrhage
were excluded. All patients underwent NCCT, CTA, and CT
perfusion (CTP) on admission. Ethical approval was obtained
from the medical ethics committee of the University Medical
Center Utrecht and local approval from all participating cen-
ters. Informed consent was obtained from patients or their
legal representatives. The medical ethics committee waived
the need for informed consent for patients who died before
informed consent could be obtained.
For the present study, we selected patients with a confirmed
occlusion in theM1 orM2 segment of the MCA on admission
CTA, as leptomeningeal collaterals are needed most if the
main blood supply to the downstream territory is completely
interrupted. Patients with an isolated occlusion of the intracra-
nial internal carotid artery without an occlusion of the M1
segment were therefore not included (n = 42). Patients were
excluded if information about clinical outcome after 90 days
was missing (Fig. 1).
Admission CT angiography
All imaging data were assessed by one of three observers with
at least 5 years of experience in neurovascular imaging,
blinded for all clinical information except for the side of symp-
toms. A detailed description of the imaging protocol has been
described elsewhere [31]. The CTA was scanned from the
aortic arch to cranium vertex, and 50–70 mL of contrast ma-
terial was injected followed by 40 mL of saline with a flow of
6 mL/s. The scan delay after contrast injection was calculated
either from time to peak arterial enhancement on CTP, or by a
trigger based onHounsfield unit threshold measurement in the
aortic arch.
Assessment of leptomeningeal collateral flow
To assess the leptomeningeal collateral circulation, the ob-
servers assessed the CTA source images and maximum inten-
sity projections (MIP) using an interactive sliding slab tech-
nique, allowing the observers to increase and decrease the
MIP slice thickness (Fig. 2). CTA source images and MIP
images were assessed for leptomeningeal collateral flow
across the entire MCA territory. The patency of the



















Fig. 1 Flowchart depicting the number of patients included in the study
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leptomeningeal collateral circulation was defined as either
poor or good [4, 8]. Poor leptomeningeal collateral status
was defined as ≤50 % collateral filling of the perfusion terri-
tory of the affected MCA or MCA branch territory [4, 8].
Possible determinants of leptomeningeal collateral flow
Patient characteristics
The selection of patient characteristics that were considered
potential determinants of leptomeningeal collateral flow was
based on previous literature. These determinants included age,
prior hypertension, prior diabetes, and systolic blood pressure
and glucose level at admission [12, 22–24].
Circle of Willis patency
Circle of Willis completeness was assessed on admission
CTA. The anterior circle of Willis pathway was considered
incomplete if the anterior communicating artery was not vis-
ible or if the A1 segment of one of the anterior cerebral arteries
was hypoplastic (<1.0 mm), absent, or both. Posterior circle of
Willis collaterals were considered incomplete if the posterior
communicating artery or P1 segment of the posterior cerebral
artery was hypoplastic (<1.0 mm) or absent ipsilateral to the
side of the perfusion deficit.
Location of the occlusion
The location of the occlusion was also assessed on admission
CTA and was classified according the most proximal part of
the occlusion, either in the intracranial internal carotid artery,
M1 segment, or M2 segment. A proximal MCA occlusion
was defined as an occlusion of the M1 segment (with or with-
out an occlusion of the intracranial internal carotid artery).
Ipsilateral extracranial internal carotid artery stenosis
or occlusion
The ipsilateral extracranial internal carotid artery was assessed
on CTA. A stenosis was measured according to the North
American Symptomatic Carotid Endarterectomy Trial
(NASCET) criteria and was considered significant if it was
>70 % [32].
Clinical outcome
The clinical outcome was assessed after 90 days with the
modified Rankin Scale (mRS) [33]. Poor clinical outcome
was defined as a score of 3–6, whereas good clinical outcome
was defined as a score of 0–2. The mRS was collected by a
trained research nurse or neurologist by telephone interview
[34].
Analyses
Single imputation was performed to account for missing data.
Continuous variables were truncated at the first and 99th per-
centile to minimize the effect of outliers [35]. First, we used
logistic regression to investigate whether patient characteris-
tics, presence of a proximal MCA occlusion, circle of Willis
completeness, or presence of an extracranial >70 % internal
carotid artery stenosis or occlusion were related to poor
leptomeningeal collateral flow. Multivariable analyses were
Fig. 2 Examples of patients with good (A) and poor leptomeningeal
collateral flow (B and C), depicted with 20-mm-thick maximum
intensity projection (MIP) reconstructions. A Good leptomeningeal
collateral flow in a patient with a right-sided ischemic stroke. There was
no proximal occlusion and the circle of Willis was complete. The 90-day
modified Rankin Scale (mRS) score was 1. B Poor leptomeningeal
collateral flow in a patient with a left-sided ischemic stroke and a
proximal occlusion in the M1 segment. The 90-day mRS was 6. C Poor
leptomeningeal collateral flow in a patient with a right-sided ischemic
stroke and an ipsilateral incomplete posterior circle of Willis. The 90-
day mRS was also 6
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performed including the significant (p < 0.05) variables from
the univariable analyses. We did not include stroke severity
and the extent of the ischemic area onNCCTand CTA in these
analyses, as these are the consequence of poor leptomeningeal
collateral flow instead of potential determinants. We also did
not adjust for treatment because this cannot be a determinant
of leptomeningeal collateral flow, since this treatment is ad-
ministered after the CTA has been made.
Next, we calculated the relative risk (RR) for the relation
between leptomeningeal collateral flow and clinical outcome
using Poisson regression [36]. We investigated whether this
relation was affected by the factors that were associated with
leptomeningeal collateral flow, by evaluating the change of
the RR in multivariable analyses after adjusting for these fac-
tors. We also assessed possible interaction effects between
these factors and patency of leptomeningeal collateral flow
in relation to clinical outcome. As stroke severity and treat-
ment can be confounding factors for the relation between
leptomeningeal collateral flow and clinical outcome, we in-
cluded them in the Poisson regressions. All analyses were
performed with R version 3.0.2.
Results
A total of 489 patients had an occlusion of an M1 or M2
segment on admission CTA (Fig. 1). After exclusion of 5 pa-
tients (1.0 %) with missing information on clinical outcome,
484 patients remained for the analyses. The mean age was 66.6
±14.6 years, 268 (55 %) patients were male, and the median
admission NIHSS was 13 (interquartile range 8–17). The most
proximal part of the occlusion was located in the M1 segment
in 234 patients (48 %) and in the M2 segment in 183 patients
(38 %). In the remaining 67 patients (14 %), there was an
occlusion of the intracranial internal carotid artery in combina-
tion with an occlusion of the M1 segment. Leptomeningeal
collateral flow was poor in 142 patients (29 %) and good in
342 patients (71%). At 90 days, 251 patients (52%) had a poor
clinical outcome. Additional patient characteristics can be
found in Table 1.
Determinants of leptomeningeal collateral flow
Univariable logistic regression analyses showed that higher
admission glucose levels, presence of a proximal intracranial
occlusion, and an incomplete ipsilateral posterior circle of
Willis were related to poor leptomeningeal collateral flow
(Table 2). Age, systolic blood pressure at admission, prior
hypertension, prior diabetes, and presence of a significant in-
ternal carotid artery stenosis or occlusion were not related to
poor leptomeningeal collateral flow.
All variables that were determinants of poor leptomeningeal
collateral flow in univariable analyses were also related to poor
leptomeningeal collateral flow in multivariable logistic regres-
sion analyses (Table 3). These analyses show that higher ad-
mission glucose levels (OR 1.1 per mmol/L increase (95 % CI
1.0–1.2)), presence of a proximal MCA occlusion (OR 1.9
(95 % CI 1.3–3.0)), and an incomplete posterior circle of
Willis (OR 1.7 (95 % CI 1.1–2.6)) were independently related
to poor leptomeningeal collateral flow.
Determinants of leptomeningeal collateral flow: effect
on the relation with clinical outcome
Poor clinical outcome was more frequent in patients with poor
leptomeningeal collateral flow (103/142 patients, 73 %) than
in patients with good leptomeningeal collateral flow (148/342
patients, 43 %). The corresponding unadjusted RR for the
relation between poor leptomeningeal collateral flow and poor
clinical outcome was 1.7 (95 % CI 1.4–2.0). In multivariable
analyses this relation was not affected by the determinants of
poor leptomeningeal collateral flow: admission glucose level,
presence of a proximal MCA occlusion, and circle of Willis
completeness (Table 4). Also, after additionally adjusting for
other confounders (stroke severity and treatment), the relation
between poor leptomeningeal collateral flow and poor clinical
outcome was not affected. Furthermore, there was no interac-
tion of admission glucose level, presence of a proximal MCA
occlusion, and circle of Willis completeness with the patency
of leptomeningeal collaterals for their relation with clinical
outcome (all interaction term p values >0.05).
Discussion
Our study shows that higher admission glucose level, the pres-
ence of an occlusion of the proximal MCA, and the presence
of an incomplete posterior circle of Willis were determinants
of poor leptomeningeal collateral flow in acute stroke patients.
Poor leptomeningeal collateral flow was related to worse clin-
ical outcome, but this relation was not influenced by admis-
sion glucose level, by the presence of a proximal MCA occlu-
sion, or by the completeness of the circle of Willis.
Different factors may determine the patency of
leptomeningeal collaterals in patients with an acute ischemic
stroke. In mice, differences in genetic background are related
to the extent of leptomeningeal collateral flow [21], and this
could also play a role in humans, possibly due to innate inter-
individual differences in the cerebral arterial vascular tree.
Furthermore, we showed that an incomplete posterior circle
of Willis ipsilateral to the occlusion, in combination with a
complete anterior circle of Willis, was related to poor
leptomeningeal collateral flow. This finding may be explained
partly by the lack of leptomeningeal collaterals between the
posterior cerebral artery andMCA territories in patients with a
fetal type posterior circle of Willis [2]. Furthermore, patency
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of circle of Willis collaterals might be an expression of the
potential to recruit collateral systems, possibly due to the same
underlying genetic mechanisms as for the development of
leptomeningeal collaterals [21]. Other circle of Willis variants
that were investigated were not related to leptomeningeal col-
lateral flow, although the numbers of patients with the combi-
nation of an incomplete anterior circle of Willis and a com-
plete posterior circle of Willis (n = 8) and patients with an
incomplete anterior and incomplete posterior circle of Willis
(n = 28) are too low for firm conclusions.
Other acquired factors that potentially could determine the
patency of leptomeningeal collaterals include vascular risk
factors and the presence of a significant stenosis or occlusion
of the internal carotid artery. The latter may also affect the size of
the circle of Willis collaterals. Previous studies about associa-
tions of vascular risk factors with leptomeningeal collaterals
were inconclusive. These studies suffered from problems such
as small sample sizes [23, 24], retrospective study designs [23,
24], or rather simple comparative analyses instead of dedicated
(regression) analyses to assess the relation with leptomeningeal
collaterals [12, 22, 23]. In our large prospective study, we did not
find a relation between age, hypertension, diabetes, and hyper-
lipidemia and poor leptomeningeal collateral flow. Neither did
we find a relation between the presence of a >70 % stenosis or
occlusion of the internal carotid artery and the patency of
leptomeningeal collaterals. Therefore, our results suggest that
exposure to vascular risk factors for atherosclerosis is not a ma-
jor contributor to the recruitment of leptomeningeal collaterals in
acute ischemic stroke. This is in contrast to the collaterals that are
recruited in response to chronic hypoxemia in peripheral artery
disease [37]. However, further studies including other vascular
risk factors (e.g., diet, weight, physical activity, cholesterol) and
other signs/markers of existing atherosclerosis should be per-
formed to further clarify the relation between cardiovascular risk
factors and leptomeningeal collateral flow.
Acute factors that are present at the time of stroke and that
may determine the patency of leptomeningeal collaterals in-
clude admission systolic blood pressure, admission glucose
level, and the location of the occlusion. Higher systolic blood
pressure at admission was not related to poor leptomeningeal
collateral flow in our study. One other study has shown that
patients with increased leptomeningeal collateral flow have a
lower systolic blood pressure than patients with normal or
decreased leptomeningeal collateral flow [12], but no other
study has confirmed this. Admission hyperglycemia has been
related previously to both poor clinical outcome after ischemic
stroke [38] and to poor leptomeningeal collateral flow [22].
Our results also show a relation between a higher admission
glucose level and poor leptomeningeal collateral flow, but it
remains unclear whether this is a true causal relation. Animal
studies have demonstrated that acute hyperglycemia could
lead to endothelial dysfunction and result in impaired collat-
eral function [39]. Stress hyperglycemia in patients with acute
ischemic stroke has been associated with poor leptomeningeal
collateral flow [22]. Furthermore, acute hyperglycemia can
reflect a pre-existing but unrecognized diabetes. Data on
HbA1c, indicating long-term elevated glucose levels, may
be used to differentiate between stress hyperglycemia and di-
abetes [38], but could not be analyzed as this was missing in
36 % of the patients in our study. However, as we did not find
a relation between prior diabetes and poor leptomeningeal
collateral flow, the effect of stress hyperglycemia probably
dominates the effect of pre-existing diabetes.
The observation that patients with a proximalMCAocclusion
often have poor leptomeningeal collateral flow has been shown
Table 1 Patient characteristics (n = 484)
Age (years) 66.6 (14.6)
Male gender 268 (55.4)
Stroke severity (NIHSS) 13 (8–17)
Time from symptom onset to scan (minutes) 100 (64–159)




Glucose (mmol/L) 6.7 (5.9–7.8)
Systolic blood pressure (mmHg) 151 (26.5)
Diastolic blood pressure (mmHg) 84 (17.2)
Medical history






Atrial fibrillation 79 (16.3)
CT angiography findings
Poor leptomeningeal collateral flow 142 (29.3)
Location of intracranial occlusion
Intracranial internal carotid artery
(and M1 segment)
67 (13.8)
M1 segment (without intracranial
internal carotid artery)
234 (48.3)
M2 segment 183 (37.8)
Circle of Willis




CoW, complete anterior CoW
296 (61.2)
Incomplete anterior CoW,
complete ipsilateral posterior CoW
8 (1.7)
Incomplete anterior and ipsilateral
posterior CoW
28 (5.8)
Significant ipsilateral extracranial >70 %
internal carotid artery stenosis or occlusion
133 (27.5)
All data are displayed as mean (standard deviation), median (interquartile
range), or n (%)
NIHSS National Institutes of Health Stroke Scale, IV-rtPA intravenous
thrombolysis with recombinant tissue type plasminogen activator, IAT
intra-arterial thrombolysis, CoW circle of Willis
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in recent studies [4, 12, 40]. In our study, the proportion of
patients with poor leptomeningeal collateral flow was 61 %
higher if there was an occlusion of the M1 segment, instead of
a more distal occlusion. There may be several explanations for
this finding. First, small ischemic areas in patients with a distal
occlusion are surrounded on all sides by adequately perfused
brain tissue, including areas supplied by non-occluded M2
branches, allowing for better leptomeningeal collateral flow.
On the other hand, patientswith a proximalMCAocclusion have
larger ischemic areas, less surrounding adequately perfused brain
tissue, and hence there are less opportunities for sufficient
leptomeningeal collateral flow. Another explanation could be
that contrast filling of distal branches via leptomeningeal collat-
erals has not yet occurred in patients with a proximal MCA
occlusion at the time the CTA is performed, as the time needed
for contrast arrival via leptomeningeal collateralsmight be longer
for patients with an M1 occlusion than for patients with a more
distal occlusion. This means that our study could have
overestimated the number of patients with a proximal occlusion
that have poor leptomeningeal collateral flow.
CTA is often used in clinical practice to image the cerebral
vasculature in acute ischemic stroke and is increasingly
Table 3 Multivariable analyses





Odds ratio 95 % confidence interval
Glucose (per mmol/L) 1.10 1.01–1.20
Proximal MCA occlusiona 1.94 1.26–2.99
Circle of Willis
Complete anterior and ipsilateral posterior CoW Reference Reference
Incomplete ipsilateral posterior CoW, complete anterior CoW 1.66 1.06–2.61
Incomplete anterior CoW, complete ipsilateral posterior CoW 0.37 0.04–3.15
Incomplete anterior and ipsilateral posterior CoW 1.02 0.37–2.76
MCA middle cerebral artery, CoW circle of Willis







flow (n = 484)
Leptomeningeal collateral flow
Good (n = 342) Poor (n = 142) Odds ratio 95 % confidence
interval
Patient characteristics
Age (years, odds ratio per decade) 66.2 (14.6) 67.5 (14.6) 1.06 0.93–1.21
Systolic blood pressure (mmHg, odds
ratio per 10 mmHg)
152 (26.4) 150 (27.0) 0.97 0.90–1.04
Glucose (mmol/L, odds ratio per mmol/L) 6.6 (5.8–7.7) 6.7 (6.2–8.4) 1.10 1.01–1.20
Hypertension 174 (50.9) 75 (52.8) 1.08 0.73–1.60
Diabetes 43 (12.6) 18 (12.7) 1.01 0.56–1.82
Hyperlipidemia 99 (28.9) 38 (26.8) 0.90 0.58–1.39
CT angiography findings
Proximal MCA occlusiona 198 (57.9) 103 (72.5) 1.92 1.25–2.94
Circle of Willis
Complete anterior and ipsilateral
posterior CoW
116 (33.9) 36 (25.4) Reference Reference
Incomplete ipsilateral posterior CoW,
complete anterior CoW
197 (57.6) 99 (69.7) 1.62 1.04–2.53
Incomplete anterior CoW, complete
ipsilateral posterior CoW
7 (2.0) 1 (0.7) 0.46 0.05–3.87
Incomplete anterior and ipsilateral
posterior CoW
22 (6.4) 6 (4.2) 0.88 0.33–2.33
Significant ipsilateral extracranial >70 %
internal carotid artery stenosis or occlusion
93 (27.2) 40 (28.2) 1.05 0.68–1.62
Data are displayed as mean (standard deviation), median (interquartile range), or n (%)
MCA middle cerebral artery, CoW circle of Willis
a Defined as an occlusion of the M1 segment with or without an occlusion of the intracranial internal carotid artery
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important to select patients for endovascular treatment. As
such, it is important to investigate leptomeningeal collateral
flow as seen on CTA. Newer techniques such as CTA recon-
struction from CTP data and multiphase CTA make the CTA
independent from timing of contrast administration and scan
acquisition and could improve assessment of the collateral
circulation [41, 42]. However, these techniques are currently
not widely available for use in clinical practice. Furthermore,
the thin slice CTP data that is needed for high-quality recon-
struction of CTA from CTP was missing in a substantial part
of our cohort. We felt that it was more important to have a
large sample size with enough power for our analyses than to
compromise on this when using newer CTA from CTP tech-
niques. The above considerations made us decide to use stan-
dard CTA instead of newer CTA techniques. Regarding the
location of the occlusion, we classified all occlusions to the
most proximal part of the occlusion. A limitation is that this
does not take the length of the thrombus into account.
Furthermore, we used a dichotomized classification of
leptomeningeal collateral flow in our analyses. Although pre-
vious studies also used this approach [8, 18, 43], this may
oversimplify the complex pathophysiology of stroke hemody-
namics. Nonetheless, through the use of a dichotomized score,
the analyses could be performed with logistic regression, mak-
ing the results better understandable and interpretable for
many physicians.
Conclusions
Our study shows that admission glucose level, a proximal
MCA occlusion, and an incomplete ipsilateral posterior circle
of Willis are determinants of leptomeningeal collateral flow
that represent a combination of congenital, acquired, and acute
factors. After adjustment for these determinants,
leptomeningeal collateral flow remains related to clinical
outcome.
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